Promotions at Astellas in the USA

26 June 2017

Japanese pharma major Astellas Pharma (TYO: 4503) today announced two senior-level promotions in its Marketing Strategy and US Commercial organizations.

Caroline Walkinshaw has been promoted to executive director, market intelligence and analytics, marketing strategy. Jacquelyn Bonnell has been promoted to national vice president, oncology sales for the US Commercial organization.

"For the past six years, Caroline has played an integral role in advancing marketing intelligence capabilities at Astellas," said Marty Golden, senior vice president of marketing strategy, adding: "I'm delighted that Caroline will continue leading the market intelligence and Analytics team to create insights in support of global strategy for our therapies."

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK